Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Swanlaab USA Ventures is a venture capital fund based in the United States, founded to invest in high-potential technologies. The firm focuses on Series A and B financing stages and is associated with sister funds that have managed over $650 million and completed more than 120 investments. Martin Hunt, Sr. serves as the founder and general managing partner.
The fund invests in B2B technology and software companies, particularly those demonstrating strong innovations and high barriers to entry. Key sectors include artificial intelligence, healthcare, and information technology. Swanlaab USA Ventures aims to achieve investment Alpha through diversification and a focus on impactful technologies.
Notable investments from Swanlaab's sister funds include XtremIO (acquired by EMC for $435 million), Soluto (acquired by Asurion for over $100 million), Oplus (acquired by Intel for over $100 million), Actimize (acquired by NICE Systems for $281 million), Precise (IPO on NASDAQ; acquired by Veritas), Zoran (IPO on NASDAQ; acquired by CSR), and M-Systems (IPO on NASDAQ; acquired by SanDisk).
Martin Hunt, Sr. - Founder and General Managing Partner, with extensive experience in venture capital and a focus on high-potential technology investments.
Submit your pitch through their website's contact form or email your deck directly to their team.
Yes, Swanlaab USA Ventures often leads investment rounds in the companies they back, particularly in Series A and B stages.
The firm is open to follow-on investments, especially in companies that demonstrate strong growth and innovation post-initial funding.
While Swanlaab USA Ventures operates with its own fund, it is associated with sister funds that manage over $650 million in total capital.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.